Antiproliferative effect of methyl-β-cyclodextrin in vitro and in human tumour xenografted athymic nude mice

British Journal of Cancer

Volumn 78, Issue 9, 1998, Pages 1165-1169

  Grosse, P Y ^a,b   Bressolle, F ^b   Pinguet, F ^a  

^a CENTRE VAL D AURELLE   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Antiproliferative activity; Methyl cyclodextrin; Nude mice; Tumour xenografts

Indexed keywords

ANTIMITOTIC AGENT; CYCLODEXTRIN DERIVATIVE; DOXORUBICIN; METHYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG LIVER LEVEL; DRUG TUMOR LEVEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 0031724078     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.648     Document Type: Article

References (29)

1. Allegre M and Deratani A (1994) Cyclodextrin uses: from concept to industrial reality. Agro Food Ind Tech 1: 9-17
2. Alley MC, Scudiero DA and Monks A (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture letrazolium assay. Cancer Res 48: 589-601
3. Arancia G and Donelli G (1991) Cell membranes as target for anticancer agents (review). Pharm Res 24: 205-217
4. Bellringer ME, Smith TG, Read R, Gopinath C and Olivier P (1995) β-cyclodextrin: 52-week toxicity studies in the rat and dog. Food Chem Toxicol 33: 367-380
5. Bressolle F, Audran M, Pham TN and Vallon JJ (1996) Cyclodextrins and enantiomeric separations of drugs by liquid chromatography and capillary electrophoresis: basic principles and new developments. A review. J Chromatogr 687: 303-336
6. Brewster ME, Estes KS and Bodor N (1990) An intravenous toxicity study of 2-hydroxypropyl-beta-cyclodextrin, a useful drug solubilizer, in rats and monkeys. Int J Pharm 59: 231-243
7. Castelli F, Puglisi G, Pignatello R and Gurrieri S (1989) Calorimetric studies of the interaction of 4-biphenylacetic acid and its β-cyclodextrin inclusion compound with lipid model membrane. Int J Pharm 52: 115-121
8. Cho MJ, Chen FJ and Huczek L (1995) Effects of inclusion complexation on the transepithelial transport of a lipophilic substance in vitro. Pharm Res 12: 560-564
9. Colangelo D, Guo HY, Connors KM, Kubota T, Sivestro L and Hoffmann RM (1992) Correlation of drug response in human tumors hislocultured in vitro with an image-analysis MTT end point and in vivo xenografted in nude mice. Anticancer Res 12: 1373-1376
10. Flourie B, Molis C, Achour L, Dupad H, Hatat C and Rambaud JC (1993) Fate of beta-cyclodextrin in the human intestine. J Nutr 123: 676-680
11. Frijlink HW, Visser J, Hefting NR, Oosting R, Meijer DKF and Lerk CF (1990) The pharmacokinetics of β-cyclodextrin and hydroxy-propyl-β-cyclodextrin in the rat. Pharm Res 7: 1248-1252
12. Frijlink HW, Franssen EJF, Eissens A, Oosting R, Lerk CF and Meijer DKF (1991) The effects of cyclodextrins on the disposition of intavenously injected drugs in the rat. Pharm Res 8: 380-384
13. Geran RI, Greenherg NH, McDonald MM, Schumacher AM and Abott BJ (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 3: 9
14. Giordano F (1941) Destino metabolico e profilo tossicologico della idrossipropilbetaciclodestrina. Boll Chim Farm 130: 239-240
15. Grosse PY, Bressolle F and Pinguet F (1997a) Methyl-β-cyclodextrin in HL-60 parent and multidrug-resislant cancer cell lines: effect on cytotoxic activity and intracellular accumulation of doxorubicin. Cancer Chemother Pharmacol 40: 489-494
16. Grosse PY, Pinguet F, Joulia JM, Astre C and Bressolle F (1997b) High-performance liquid chromatographic assay for methyl-β-cyclodextrin in plasma and cell lysate. J Chromatogr B 694: 219-226
17. Grosse PY, Bressolle F and Pinguet F (1998) In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrin. Eur J Cancer 34: 168-174
18. Heo DS, Park JG, Hata K, Day R, Heberman RB and Whiteside TL (1990) Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res 30: 3681-3689
19. Hirayama F and Uekama K (1987) Cyclodextrins and Their Industrial Uses. Duchêne D (ed.). Editions de Santé: Paris
20. Hovgaard L and Brøndsted H (1995) Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm Res 12: 1328-1332
21. Kilsdonk EPC, Yancey PG, Stoudt GW, Wen Bangerter F, Johnson WJ, Phillips MC and Rothblat GH (1995) Cellular cholesterol efflux mediated by cyclodextrins. J Biol Biochem 270: 17250-17256
22. Krishnamoorthy R, Wolka AM, Zezhi S and Mitra AK (1995) Cyclodextrins as mucosal absorption promoters. IV. Evaluation of nasal mucotoxicity. Eur J Biopharm 41: 296-301
23. Minnaugh EG, Fairchild CR, Fruehauf JP and Sinka BK (1991) Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidnig-resistant human breast tumor xenografts in athymic nude mice. Biochem Pharmacol 42: 391-402
24. Muggia FM and Green MD (1991) New anthracycline antitumor antibiotics. Crit Rev Oncol Hematol 11: 43-64
25. Soule HD, Vasquez J, Long A, Albert S and Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416
26. Stekar J, Hilgard P and Klenner T (1995) Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide. Eur J Cancer 31: 372-374
27. Szejtli J (1994) Medicinal applications of cyclodextrins. Med Res Rev 14: 353-386
28. Szejtli J, Cserhàti T and Szögyi M (1986) Interactions between cyclodextrins and cell-membrane phospholipids. Carbohyd Polym 6: 35-49
29. Tomayko MM and Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148-154